Myc-nick: a Cytoplasmic Cleavage Product of Myc That Promotes Alpha-tubulin Acetylation and Cell Differentiation

Overview

Journal Cell

Publisher Cell Press

Specialty Cell Biology

Date 2010 Aug 10

PMID 20691906

Citations 122

Authors

Maralice Conacci-Sorrell

Celine Ngouenet

Robert N Eisenman

Affiliations

Soon will be listed here.

Abstract

The Myc oncoprotein family comprises transcription factors that control multiple cellular functions and are widely involved in oncogenesis. Here we report the identification of Myc-nick, a cytoplasmic form of Myc generated by calpain-dependent proteolysis at lysine 298 of full-length Myc. Myc-nick retains conserved Myc box regions but lacks nuclear localization signals and the bHLHZ domain essential for heterodimerization with Max and DNA binding. Myc-nick induces alpha-tubulin acetylation and altered cell morphology by recruiting histone acetyltransferase GCN5 to microtubules. During muscle differentiation, while the levels of full-length Myc diminish, Myc-nick and acetylated alpha-tubulin levels are increased. Ectopic expression of Myc-nick accelerates myoblast fusion, triggers the expression of myogenic markers, and permits Myc-deficient fibroblasts to transdifferentiate in response to MyoD. We propose that the cleavage of Myc by calpain abrogates the transcriptional inhibition of differentiation by full-length Myc and generates Myc-nick, a driver of cytoplasmic reorganization and differentiation.

Citing Articles

c-Myc and FOXO3a-The Everlasting Decision Between Neural Regeneration and Degeneration.

Khaitin A, Guzenko V, Bachurin S, Demyanenko S Int J Mol Sci. 2024; 25(23).

PMID: 39684331 PMC: 11641098. DOI: 10.3390/ijms252312621.

Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome-lysosome fusion in dystrophin-deficient mdx mice.

Agrawal A, Clayton E, Cavazos C, Clayton B, Rodney G Acta Physiol (Oxf). 2024; 241(1):e14243.

PMID: 39422111 PMC: 11680461. DOI: 10.1111/apha.14243.

Mycb and Mych stimulate Müller glial cell reprogramming and proliferation in the uninjured and injured zebrafish retina.

Lee M, Jui J, Sahu A, Goldman D Development. 2024; 151(14).

PMID: 38984586 PMC: 11369687. DOI: 10.1242/dev.203062.

Acetylation of c-Myc at Lysine 148 Protects Neurons After Ischemia.

Guzenko V, Bachurin S, Dzreyan V, Khaitin A, Kalyuzhnaya Y, Demyanenko S Neuromolecular Med. 2024; 26(1):8.

PMID: 38546874 DOI: 10.1007/s12017-024-08777-2.

c-Myc Drives inflammation of the maternal-fetal interface, and neonatal lung remodeling induced by intra-amniotic inflammation.

Tan A, Tong X, Alvarez-Cubela S, Chen P, Santana A, Morales A Front Cell Dev Biol. 2024; 11:1245747.

PMID: 38481391 PMC: 10933046. DOI: 10.3389/fcell.2023.1245747.

References

Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D . In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 2002; 21(24):6820-31. PMC: 139102. DOI: 10.1093/emboj/cdf682. View

Small G, Chou T, Dang C, Orlowski R . Evidence for involvement of calpain in c-Myc proteolysis in vivo. Arch Biochem Biophys. 2002; 400(2):151-61. DOI: 10.1016/S0003-9861(02)00005-X. View

Hann S, King M, Bentley D, Anderson C, Eisenman R . A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell. 1988; 52(2):185-95. DOI: 10.1016/0092-8674(88)90507-7. View

Eilers M, Eisenman R . Myc's broad reach. Genes Dev. 2008; 22(20):2755-66. PMC: 2751281. DOI: 10.1101/gad.1712408. View

Pietilainen T, Lipponen P, Aaltomaa S, Eskelinen M, Kosma V, Syrjanen K . Expression of c-myc proteins in breast cancer as related to established prognostic factors and survival. Anticancer Res. 1995; 15(3):959-64. View

Spotts G, Patel S, Xiao Q, Hann S . Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol. 1997; 17(3):1459-68. PMC: 231871. DOI: 10.1128/MCB.17.3.1459. View

North B, Marshall B, Borra M, Denu J, Verdin E . The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell. 2003; 11(2):437-44. DOI: 10.1016/s1097-2765(03)00038-8. View

Koch H, Zhang R, Verdoodt B, Bailey A, Zhang C, Yates 3rd J . Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. Cell Cycle. 2007; 6(2):205-17. DOI: 10.4161/cc.6.2.3742. View

Arthur J, Elce J, Hegadorn C, Williams K, Greer P . Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol Cell Biol. 2000; 20(12):4474-81. PMC: 85815. DOI: 10.1128/MCB.20.12.4474-4481.2000. View

10.

Taira T, Maeda J, Onishi T, Kitaura H, Yoshida S, Kato H . AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC. Genes Cells. 1998; 3(8):549-65. DOI: 10.1046/j.1365-2443.1998.00206.x. View

11.

Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E . Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell. 2004; 6(5):673-84. DOI: 10.1016/s1534-5807(04)00107-8. View

12.

Dedieu S, Poussard S, Mazeres G, Grise F, Dargelos E, Cottin P . Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp Cell Res. 2004; 292(1):187-200. DOI: 10.1016/j.yexcr.2003.08.014. View

13.

Okano H, Park W, Corradi J, Darnell R . The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survival. Genes Dev. 1999; 13(16):2087-97. PMC: 316965. DOI: 10.1101/gad.13.16.2087. View

14.

Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N . Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995; 81(1):27-40. DOI: 10.1016/0092-8674(95)90368-2. View

15.

Sterner D, Berger S . Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev. 2000; 64(2):435-59. PMC: 98999. DOI: 10.1128/MMBR.64.2.435-459.2000. View

16.

Alexandrova N, Niklinski J, Bliskovsky V, Otterson G, Blake M, Kaye F . The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol Cell Biol. 1995; 15(9):5188-95. PMC: 230766. DOI: 10.1128/MCB.15.9.5188. View

17.

Tworkowski K, Salghetti S, Tansey W . Stable and unstable pools of Myc protein exist in human cells. Oncogene. 2002; 21(55):8515-20. DOI: 10.1038/sj.onc.1205976. View

18.

Welcker M, Orian A, Jin J, Grim J, Grim J, Harper J . The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A. 2004; 101(24):9085-90. PMC: 428477. DOI: 10.1073/pnas.0402770101. View

19.

Ivanov A, McCall I, Babbin B, Samarin S, Nusrat A, Parkos C . Microtubules regulate disassembly of epithelial apical junctions. BMC Cell Biol. 2006; 7:12. PMC: 1444913. DOI: 10.1186/1471-2121-7-12. View

20.

Xiao Q, Claassen G, Shi J, Adachi S, Sedivy J, Hann S . Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev. 1998; 12(24):3803-8. PMC: 317265. DOI: 10.1101/gad.12.24.3803. View